New Updates is Archive: from ADA & AACEPharmacology UpdatesCo-Morbidities & Treatment RecommendationsMinimizing Biomechanical ComplicationsManaging Acute ComplicationsSpecial Considerations for Special PopulationsDIABETES…Alarming Increases, Devastating Costs, Crippling the Future of America!.
Archive: New Updates from ADA & AACEPharmacology UpdatesCo-Morbidities & Treatment RecommendationsMinimizing Biomechanical ComplicationsManaging Acute ComplicationsSpecial Considerations for Special PopulationsDIABETES…Alarming Increases, Devastating Costs, Crippling the Future of America!
you is Every time watch the news it confirms that you are caring for today’s most common and most complicated patients..
Every time you watch the news it confirms that you are caring for today’s most common and most complicated patients.
The prevention and treatment guidelines is seem to change constantly, the patients are getting younger and sicker and you are busier than ever!.
The prevention and treatment guidelines seem to change constantly, the patients are getting younger and sicker and you are busier than ever!
you is Are left wondering how you can make a difference in your patients’ lives?Expert Mary Ann Rosa works directly with the most challenging patients with diabetes and understands how difficult it is to manage this complex disease..
Are you left wondering how you can make a difference in your patients’ lives?Expert Mary Ann Rosa works directly with the most challenging patients with diabetes and understands how difficult it is to manage this complex disease.
this seminar is Attend and increase your understanding of the latest treatment guidelines and pharmacologic interventions..
Attend this seminar and increase your understanding of the latest treatment guidelines and pharmacologic interventions.
Mary Ann is will provide strategies to optimize patient outcomes and practical tips you can use to educate and empower your patients..
Mary Ann will provide strategies to optimize patient outcomes and practical tips you can use to educate and empower your patients.
this opportunity is Don’t miss to improve the care you provide to patients with diabetes.OUTLINENew RecommendationsAmerican Diabetes Association (ADA)All NEW 2015 Standards of CareBMI ClassificationsE-cigarettesImmunization RecommendationsAmerican Association of Clinical Endocrinologists (AACE)Updates to the ComprehensiveDiabetes AlgorithmReimbursement StrategiesCardiometabolic DiseaseDyslipidemiaNew American College of Cardiology GuidelinesRecommended Treatment Based on Risk FactorsCritical Lab ValuesStatin TherapyNon-statin LDL-C-lowering TherapyFibratesOmega 3NiacinHypertensionModifications in Diagnostic CriteriaBeta-BlockersCalcium Channel BlockersDiureticsLow Dose vs..
Don’t miss this opportunity to improve the care you provide to patients with diabetes.OUTLINENew RecommendationsAmerican Diabetes Association (ADA)All NEW 2015 Standards of CareBMI ClassificationsE-cigarettesImmunization RecommendationsAmerican Association of Clinical Endocrinologists (AACE)Updates to the ComprehensiveDiabetes AlgorithmReimbursement StrategiesCardiometabolic DiseaseDyslipidemiaNew American College of Cardiology GuidelinesRecommended Treatment Based on Risk FactorsCritical Lab ValuesStatin TherapyNon-statin LDL-C-lowering TherapyFibratesOmega 3NiacinHypertensionModifications in Diagnostic CriteriaBeta-BlockersCalcium Channel BlockersDiureticsLow Dose vs.
Aggressive TherapyBiomechanical ComplicationsNew Guidelines is for AssessmentFoot Exam & Treatment AlterationsSkin AssessmentUlcersStrategies for Patient ComplianceRecurrence PreventionNeurological PredispositionPeripheral & AutonomicNeuropathiesVascular ConsiderationsMicrovascular changesChallenges with RetinopathiesNon-Insulin MedicationsAACE Profiles & RecommendationsSulfonylureasMeglitinidesThiazolidinedionesBiaguanidesAlpha-glucosidase InhibitorsDPP-4 InhibitorsSGLT-2 InhibitorsBlood Glucose Pattern Analysis2015 Glycemic TargetsAdjusting TreatmentUtilizing CGMIndividualized Glycemic Treatment GoalsMonotherapyDual TherapyBenefit of Early, Aggressive ControlWhen to Transition to InsulinProgressive B-cell FailureInsulin ProfilesBasal TherapyIntensifying TherapyBenefits of Insulin Pump TherapyNew OptionsSensor-augmentedClosed Loop TherapyManagement Strategies for Acute ComplicationsDiabetic Ketoacidosis (DKA)Hyperglycemic Hyperosmolar Non-ketotic Syndrome (HHNK)InfectionSurgery & HospitalizationAddressing Special PopulationsType II in Children/AdolescentsVariations in Targets and TherapiesElderlyImpact of Co-MorbiditiesPutting it All TogetherAADE-7 Behavioral GoalsStrategies for ComplianceMotivating ChangeOBJECTIVESCommunicate the various pharmacologic treatment options for diabetes.Breakdown effective new strategies to improve patient outcomes.Formulate a plan of care for the patient with complications related to diabetes.Integrate motivational interviewing strategies to facilitate patient behavioral changes.Evaluate biomechanical treatment strategies to improve patient outcomes.Assess the new recommendations for cardiometabolic disease.Develop management strategies for the patient experiencing a diabetic emergency..
Aggressive TherapyBiomechanical ComplicationsNew Guidelines for AssessmentFoot Exam & Treatment AlterationsSkin AssessmentUlcersStrategies for Patient ComplianceRecurrence PreventionNeurological PredispositionPeripheral & AutonomicNeuropathiesVascular ConsiderationsMicrovascular changesChallenges with RetinopathiesNon-Insulin MedicationsAACE Profiles & RecommendationsSulfonylureasMeglitinidesThiazolidinedionesBiaguanidesAlpha-glucosidase InhibitorsDPP-4 InhibitorsSGLT-2 InhibitorsBlood Glucose Pattern Analysis2015 Glycemic TargetsAdjusting TreatmentUtilizing CGMIndividualized Glycemic Treatment GoalsMonotherapyDual TherapyBenefit of Early, Aggressive ControlWhen to Transition to InsulinProgressive B-cell FailureInsulin ProfilesBasal TherapyIntensifying TherapyBenefits of Insulin Pump TherapyNew OptionsSensor-augmentedClosed Loop TherapyManagement Strategies for Acute ComplicationsDiabetic Ketoacidosis (DKA)Hyperglycemic Hyperosmolar Non-ketotic Syndrome (HHNK)InfectionSurgery & HospitalizationAddressing Special PopulationsType II in Children/AdolescentsVariations in Targets and TherapiesElderlyImpact of Co-MorbiditiesPutting it All TogetherAADE-7 Behavioral GoalsStrategies for ComplianceMotivating ChangeOBJECTIVESCommunicate the various pharmacologic treatment options for diabetes.Breakdown effective new strategies to improve patient outcomes.Formulate a plan of care for the patient with complications related to diabetes.Integrate motivational interviewing strategies to facilitate patient behavioral changes.Evaluate biomechanical treatment strategies to improve patient outcomes.Assess the new recommendations for cardiometabolic disease.Develop management strategies for the patient experiencing a diabetic emergency.